These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
806 related items for PubMed ID: 19265453
1. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy. McGready R, Tan SO, Ashley EA, Pimanpanarak M, Viladpai-Nguen J, Phaiphun L, Wüstefeld K, Barends M, Laochan N, Keereecharoen L, Lindegardh N, Singhasivanon P, White NJ, Nosten F. PLoS Med; 2008 Dec 23; 5(12):e253. PubMed ID: 19265453 [Abstract] [Full Text] [Related]
2. A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. Hutagalung R, Paiphun L, Ashley EA, McGready R, Brockman A, Thwai KL, Singhasivanon P, Jelinek T, White NJ, Nosten FH. Malar J; 2005 Sep 22; 4():46. PubMed ID: 16179089 [Abstract] [Full Text] [Related]
3. Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria. Nyunt MM, Nguyen VK, Kajubi R, Huang L, Ssebuliba J, Kiconco S, Mwima MW, Achan J, Aweeka F, Parikh S, Mwebaza N. Antimicrob Agents Chemother; 2015 Dec 14; 60(3):1274-82. PubMed ID: 26666942 [Abstract] [Full Text] [Related]
4. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. West African Network for Clinical Trials of Antimalarial Drugs (WANECAM). Lancet; 2018 Apr 07; 391(10128):1378-1390. PubMed ID: 29606364 [Abstract] [Full Text] [Related]
5. A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border. Saito M, Carrara VI, Gilder ME, Min AM, Tun NW, Pimanpanarak M, Viladpai-Nguen J, Paw MK, Haohankhunnatham W, Konghahong K, Phyo AP, Chu C, Turner C, Lee SJ, Duanguppama J, Imwong M, Bancone G, Proux S, Singhasivanon P, White NJ, Nosten F, McGready R. BMC Med; 2021 Jun 10; 19(1):132. PubMed ID: 34107963 [Abstract] [Full Text] [Related]
6. Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria. Tarning J, McGready R, Lindegardh N, Ashley EA, Pimanpanarak M, Kamanikom B, Annerberg A, Day NP, Stepniewska K, Singhasivanon P, White NJ, Nosten F. Antimicrob Agents Chemother; 2009 Sep 10; 53(9):3837-46. PubMed ID: 19564366 [Abstract] [Full Text] [Related]
7. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. van der Pluijm RW, Tripura R, Hoglund RM, Pyae Phyo A, Lek D, Ul Islam A, Anvikar AR, Satpathi P, Satpathi S, Behera PK, Tripura A, Baidya S, Onyamboko M, Chau NH, Sovann Y, Suon S, Sreng S, Mao S, Oun S, Yen S, Amaratunga C, Chutasmit K, Saelow C, Runcharern R, Kaewmok W, Hoa NT, Thanh NV, Hanboonkunupakarn B, Callery JJ, Mohanty AK, Heaton J, Thant M, Gantait K, Ghosh T, Amato R, Pearson RD, Jacob CG, Gonçalves S, Mukaka M, Waithira N, Woodrow CJ, Grobusch MP, van Vugt M, Fairhurst RM, Cheah PY, Peto TJ, von Seidlein L, Dhorda M, Maude RJ, Winterberg M, Thuy-Nhien NT, Kwiatkowski DP, Imwong M, Jittamala P, Lin K, Hlaing TM, Chotivanich K, Huy R, Fanello C, Ashley E, Mayxay M, Newton PN, Hien TT, Valecha N, Smithuis F, Pukrittayakamee S, Faiz A, Miotto O, Tarning J, Day NPJ, White NJ, Dondorp AM, Tracking Resistance to Artemisinin Collaboration. Lancet; 2020 Apr 25; 395(10233):1345-1360. PubMed ID: 32171078 [Abstract] [Full Text] [Related]
9. A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya. Juma EA, Obonyo CO, Akhwale WS, Ogutu BR. Malar J; 2008 Dec 22; 7():262. PubMed ID: 19102746 [Abstract] [Full Text] [Related]
11. Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria. Bukirwa H, Unnikrishnan B, Kramer CV, Sinclair D, Nair S, Tharyan P. Cochrane Database Syst Rev; 2014 Mar 04; (3):CD006404. PubMed ID: 24596021 [Abstract] [Full Text] [Related]
12. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. Lefèvre G, Looareesuwan S, Treeprasertsuk S, Krudsood S, Silachamroon U, Gathmann I, Mull R, Bakshi R. Am J Trop Med Hyg; 2001 Mar 04; 64(5-6):247-56. PubMed ID: 11463111 [Abstract] [Full Text] [Related]
13. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India. Valecha N, Srivastava P, Mohanty SS, Mittra P, Sharma SK, Tyagi PK, Pradhan K, Dev V, Singh R, Dash AP, Sharma YD. Malar J; 2009 May 19; 8():107. PubMed ID: 19454000 [Abstract] [Full Text] [Related]
15. Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria. Zani B, Gathu M, Donegan S, Olliaro PL, Sinclair D. Cochrane Database Syst Rev; 2014 Jan 20; 2014(1):CD010927. PubMed ID: 24443033 [Abstract] [Full Text] [Related]
16. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O. Malar J; 2009 Jun 08; 8():125. PubMed ID: 19505304 [Abstract] [Full Text] [Related]
17. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India. Bharti PK, Shukla MM, Ringwald P, Krishna S, Singh PP, Yadav A, Mishra S, Gahlot U, Malaiya JP, Kumar A, Prasad S, Baghel P, Singh M, Vadadi J, Singh MP, Bustos MD, Ortega LI, Christophel EM, Kashyotia SS, Sonal GS, Singh N. Malar J; 2016 Oct 13; 15(1):498. PubMed ID: 27737665 [Abstract] [Full Text] [Related]
18. Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial. Meremikwu M, Alaribe A, Ejemot R, Oyo-Ita A, Ekenjoku J, Nwachukwu C, Ordu D, Ezedinachi E. Malar J; 2006 May 16; 5():43. PubMed ID: 16704735 [Abstract] [Full Text] [Related]
19. Artesunate + amodiaquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in the Colombian Pacific region: a noninferiority trial. De la Hoz Restrepo F, Porras Ramírez A, Rico Mendoza A, Córdoba F, Rojas DP. Rev Soc Bras Med Trop; 2012 Dec 16; 45(6):732-8. PubMed ID: 23295878 [Abstract] [Full Text] [Related]
20. Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Ndiaye JL, Faye B, Gueye A, Tine R, Ndiaye D, Tchania C, Ndiaye I, Barry A, Cissé B, Lameyre V, Gaye O. Malar J; 2011 Aug 12; 10():237. PubMed ID: 21838909 [Abstract] [Full Text] [Related] Page: [Next] [New Search]